Cypress, Forest win FDA clearance for fibromyalgia drug

01/14/2009 | Reuters

The FDA cleared Savella, a treatment for fibromyalgia from Forest Laboratories and Cypress Bioscience. Fibromyalgia is a chronic ailment marked by extensive pain and reduced physical function. The companies said they expect to launch the drug by March.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY